Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00977938 · ClinicalTrials.gov registry record · Phase 4
The Dual Antiplatelet Therapy Study (DAPT Study)
A Phase 4 study, sponsored by Baim Institute for Clinical Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 25,682
- Enrollment target
NCT00977938: Completed Phase 4 study, sponsored by Baim Institute for Clinical Research.
NCT00977938 is a Phase 4 study that has completed, run by Baim Institute for Clinical Research. The registered enrollment target is 25,682 participants, above the 516-participant average among 9,235 other Phase 4 trials with a reported enrollment target (4877% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00977938, a Phase 4 study, has completed, sponsored by Baim Institute for Clinical Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25,682 participants
- Enrollment target
Study Summary
The DAPT Study is a double blind randomized controlled trial intended to determine the appropriate duration for dual antiplatelet therapy (the combination of aspirin and a second anti-clotting medication) as well as the safety and effectiveness of dual antiplatelet therapy to protect patients from stent thrombosis and major adverse cardiovascular and cerebrovascular events (MACCE) following the implantation of drug-eluting coronary stents. Similar analysis will be conducted in a smaller cohort of bare metal coronary stent - treated subjects.
Primary Outcome
The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of ARC definite or probable stent thrombosis within randomized DES ITT patients between 12 and 30 months post procedure.
Interventions
- DRUG Placebo & Aspirin
- DRUG Clopidogrel & Aspirin, Prasugrel & Aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,682 participants |
| Start Date | 2009-10 |
| Est. Completion | 2014-06 |
| Phase | Phase 4 |
What the finished NCT00977938 record still lists
NCT00977938 is an interventional study that assigns participants to a tested intervention. Its 25,682 participants enrollment target places it among the larger protocols in the corpus, above the 516-participant average among 9,235 other Phase 4 trials with a reported enrollment target (4877% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo & Aspirin is the first listed.
NCT00977938 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00977938 about?
NCT00977938 is a clinical study titled "The Dual Antiplatelet Therapy Study (DAPT Study)". The DAPT Study is a double blind randomized controlled trial intended to determine the appropriate duration for dual antiplatelet therapy (the combination of aspirin and a second anti-clotting medication) as well as the safety and effectiveness of dual antiplatelet therapy to protect patients from s...
What is the current status of trial NCT00977938?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25,682 participants. The study started on 2009-10. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00977938?
The interventions under investigation include: Placebo & Aspirin (DRUG), Clopidogrel & Aspirin, Prasugrel & Aspirin (DRUG).
Who is sponsoring clinical trial NCT00977938?
This trial is sponsored by Baim Institute for Clinical Research, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00977938's enrollment target sits among peer trials
25,682 5th of 2000 higher than 1,996 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
- NCT04595201 · 25,000 participants
Clinical Follow-up of Pregnant Subjects Undergoing NIPT
- NCT04994015 · 25,000 participants
Parkinson's Foundation PD GENEration Genetic Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia